Inotiv
Inotiv 2026-2027 Product Guide

2026-2027 Product Guide

New research model pricing is now available!

Download Now
Inotiv welfareplus+ Enrichment

welfareplus+
Enrichment: Elevating
Lab Animal Care

Maximize animal well-being and research
quality with our enrichment solutions.

Learn more
Inotiv Hypertension Models: Clearer Insights

Hypertension Models.
Clearer Insights.

Get our free guide to translational models that
deliver reliable data and de-risk decisions early.

Download the guide
Inotiv Monoclonal antibody production

Monoclonal antibody
production

Secure your source for quality antibody
production. Learn how our experience and
flexibility can meet your needs for both small
scale and large scale production.

Download the guide
Inotiv Pathology/Histology 3xIF GFP Liver

Digital Pathology

Learn how our whole slide imaging and
precision AI-driven quantitative image analysis
can support your drug discovery and
development projects.

Download the guide
Inotiv ADC targets for oncology and other therapeutics

Assays in Focus

Developing Antibody Drug Conjugate (ADC)
therapeutics? Inotiv has mass spectrometry
assays to quantify your ADC target protein in
any sample type, including FFPE tissue, without
antibodies. We have developed assays to 27
ADC targets for oncology and other therapeutic
applications.

Download Now

Expect More From Your Discovery, Development and
Research Models Partner

Explore Our Full Offering of Services and Products

inotiv-lab-technicians-1

Discovery and Development

Inotiv delivers a broad array of nonclinical and analytical services from discovery through clinical development.  

LEARN MORE
hp-hero-request-a-sample-1

Research Models and Services

Inotiv provides the broadest range of research models and related services to pharmaceutical and biotech companies, government, academia, and other life science organizations.  

LEARN MORE

The Latest From Inotiv

[Webinar] NHP Enrichment

Thursday, October 8, 2026 11:00 am EDT On-Demand Webinar Move Beyond Static Routines Environmental enrichment is a cornerstone of non-human primate (NHP) care, designed to promote...

American Association for Laboratory Animal Science (AALAS)

October 25-29, 2026 Houston, TX Booth #1716 Each fall since 1950, the American Association for Laboratory Animal Science has held its annual National Meeting. During the five days of...

Neuroscience

November 14-18, 2026 Washington, D.C. Booth #937 Each year, scientists from around the world congregate to discover new ideas, share their research, and experience the best the field has...

American College of Toxicology (ACT)

November 15-18, 2026 San Antonio, TX Booth #311 ACT is a global community of professional scientists representing the pharmaceutical and biotech industries, regulatory agencies, contract...

Inotiv Successfully Completes Financial Restructuring Process

July 20, 2026 Inotiv Successfully Completes Financial Restructuring Process Emerges from Chapter 11 with a stronger balance sheet, well...

Inotiv Announces Confirmation of Plan of Reorganization

July 14, 2026 Marks critical milestone in financial restructuring process, positioning Inotiv to emerge well-capitalized, with an improved...

Inotiv Reaches Agreement to Strengthen Capital Structure and Position Company for Future Growth

June 3, 2026 Receives commitments for $65 million in new money financing to support ongoing business operations Recapitalization...

ON-DEMAND WEBINAR

Breaking Barriers: Choosing the Right Partner for Large-Scale Rederivation Success

Undertaking a large-scale rederivation project can be complex and resource-intensive, with hundreds of animal lines at stake. Choosing the...

SCIENTIFIC POSTER

Comparative Evaluation of Different Plating Methodologies and Sources of Induced S9 Metabolic Activation on the Mutagenic Potential of N-Nitrosodipropylamine Using the Ames Test

Due to the current FDA concern and guidance on reducing the risk of Nitrosamine impurities in human drugs, there has been an increased...

Decoration

Subscribe to updates for Inotiv

Sign up and you'll receive the latest updates that matter to you, delivered straight to your inbox.

SUBSCRIBE NOW